The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

16 Feb 2024 12:30

RNS Number : 4808D
Location Sciences Group PLC
16 February 2024
 

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

16 February 2024

 

Location Sciences Group PLC

("Location Sciences" or the "Company" or the "Group")

 

Result of General Meeting

 

Location Sciences (AIM: LSAI) is pleased to announce that at the Company's General Meeting held earlier today, all resolutions proposed, including the special resolutions, were duly passed. Accordingly, the Proposals set out in the Admission Document are now expected to complete, conditional on Admission, on 19 February 2024.

 

Change of name

 

The Company's change of name to "Sorted Group Holdings Plc" and change of AIM ticker symbol to "SORT" will take place once Companies House has issued a new certificate of incorporation reflecting the change of name. The change of name is expected to become effective imminently and the Company will make a further announcement following the completion of the change of name.

 

Change of website

 

In order to reflect the Company's new name, the Company's website will be changed to www.sorted.com with effect from Admission. The information required pursuant to AIM Rule 26 will be available at this address.

 

Share Consolidation

 

As a result of the passing of the Resolutions, the Share Consolidation will become effective as of 6.00 p.m. on 16 February 2024 and every 625 Existing Ordinary Shares will be consolidated into one New Ordinary Share with a nominal value of 62.5p each. Accordingly, the New Ordinary Shares, including the Subscription Shares, the Remuneration Shares and the CLN Shares are expected to be admitted to trading on AIM with effect from 8.00 a.m. on 19 February 2024 under the new ISIN and SEDOL of GB00BPDX2041 and BPDX204 respectively.

 

Application for Admission and Total Voting Rights

 

Application has been made for the Enlarged Share Capital of 7,639,705 New Ordinary Shares to be admitted to trading on AIM and it is expected that Admission will become effective on 19 February 2024.

 

Following Admission, the Company will have 7,639,705 Ordinary Shares in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company's total number of Ordinary Shares and voting rights will be 7,639,705. This figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Detailed results from the General Meeting

 

At the General Meeting held earlier today all resolutions were duly passed on a show of hands with the following table summarising proxy votes:

 

Resolution

Votes for

Votes against

Approval

Withheld

Ordinary Resolutions

Shares

Shares

%

Shares

1. To approve the Acquisition under resolution 1

1,641,451,823

 

242,683

 

99.98

 

25,344

 

2. To approve the Share Consolidation under resolution 2

1,641,146,113

 

548,393

 

99.96

 

25,344

 

3. Authorise the Directors to allot the Remuneration Shares under resolution 3

1,641,153,906

 

527,528

 

99.97

 

38,416

 

Special Resolutions

4. Authorise the Directors to allot the Equity Shares under resolution 4

1,641,322,007

 

362,489

 

99.98

 

35,354

 

5. Change the name of the Company to Sorted Group Holdings Plc under resolution 5

1,641,401,823

 

282,673

 

99.98

 

35,354

 

 

The number of Existing Ordinary Shares in issue at the time of the General Meeting on 16 February 2024 was 2,647,587,500. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes 'For' or 'Against' a resolution.

 

The same definitions apply throughout this announcement as those set out in the Admission Document published on 30 January 2024, unless the context requires otherwise. 

 

For further information please contact:

 

Location Sciences Group PLC via Allenby Capital

Simon Wilkinson, Chairman

 

Allenby Capital Limited (Nominated Adviser) Tel: +44 (0)20 3328 5656

David Hart

Vivek Bhardwaj

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMQKABBBBKDFBD
Date   Source Headline
1st Jun 20207:00 amRNSIssue of Equity and Total Voting Rights
11th May 20201:51 pmRNSHolding(s) in Company
11th May 20201:50 pmRNSHolding(s) in Company
7th May 20202:06 pmRNSSecond Price Monitoring Extn
7th May 20202:00 pmRNSPrice Monitoring Extension
6th May 202010:42 amRNSIssue of Equity and Total Voting Rights
1st May 20202:06 pmRNSSecond Price Monitoring Extn
1st May 20202:00 pmRNSPrice Monitoring Extension
29th Apr 202011:06 amRNSSecond Price Monitoring Extn
29th Apr 202011:01 amRNSPrice Monitoring Extension
20th Apr 20203:16 pmRNSIssue of Equity and Total Voting Rights
9th Apr 202012:17 pmRNSResult of AGM
9th Apr 20207:00 amRNSAGM statement
8th Apr 202010:11 amRNSHolding(s) in Company
3rd Apr 20202:06 pmRNSHolding(s) in Company
3rd Apr 20207:00 amRNSAttendance at the Company’s AGM
1st Apr 20204:45 pmRNSHolding(s) in Company
31st Mar 202010:12 amRNSHolding(s) in Company
31st Mar 202010:10 amRNSHolding(s) in Company
26th Mar 202011:50 amRNSResult of GM, Appointment of Joint Broker and TVR
26th Mar 20207:00 amRNSIssue of Warrants
23rd Mar 202012:00 pmRNSCovid-19 Update
16th Mar 20203:33 pmRNSNotice of GM
16th Mar 20207:00 amRNSAnnual Financial Report
6th Mar 20204:04 pmRNSConditional Placing and Share Re-organisation
3rd Mar 20207:00 amRNSGlobal Master Service Agreement and Partnership
28th Feb 20202:05 pmRNSSecond Price Monitoring Extn
28th Feb 20202:00 pmRNSPrice Monitoring Extension
26th Feb 20202:51 pmRNSStatement Regarding Share Price Movement
24th Jan 202010:09 amRNSHolding(s) in Company
23rd Jan 20207:00 amRNSReport: The State of Privacy & Location Marketing
20th Jan 202011:41 amRNSIssue of Equity and Total Voting Rights
15th Jan 20202:00 pmRNSTrading Update and Partnership with X-Mode
17th Dec 20199:00 amRNSHolding(s) in Company
17th Dec 20198:56 amRNSHolding(s) in Company
12th Nov 20192:45 pmRNSMello London 2019 Presentation
28th Oct 201911:00 amRNSLocation Sciences to present at Mello London 2019
28th Oct 20198:57 amRNSLocation Sciences to present at Mello London 2019
7th Oct 20194:12 pmRNSHolding(s) in Company
7th Oct 20194:09 pmRNSHolding(s) in Company
27th Sep 201911:18 amRNSResult of Placing
26th Sep 20196:24 pmRNSUpdate re Placing
26th Sep 20197:01 amRNSProposed Placing
26th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSContract with Vicinity Media
5th Sep 20197:00 amRNSPartnership with Blis
2nd Sep 20199:29 amRNSAdvisory Panel Appointment
1st Aug 20198:31 amRNSTrading Update and Appointment
15th Jul 20197:00 amRNSLocation Sciences appoints Andy Roberts
24th Jun 20191:38 pmRNSDirector's Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.